Innate Lymphoid Cells in Skin Homeostasis and Malignancy
Innate lymphoid cells (ILCs) are mostly tissue resident lymphocytes that are preferentially enriched in barrier tissues such as the skin. Although they lack the expression of somatically rearranged antigen receptors present on T and B cells, ILCs partake in multiple immune pathways by regulating tis...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.758522/full |
id |
doaj-9e6611efe45b4ca68588da5b243b22e4 |
---|---|
record_format |
Article |
spelling |
doaj-9e6611efe45b4ca68588da5b243b22e42021-10-08T06:34:12ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-10-011210.3389/fimmu.2021.758522758522Innate Lymphoid Cells in Skin Homeostasis and MalignancyMarek Wagner0Marek Wagner1Shigeo Koyasu2Laboratory for Immune Cell Systems, RIKEN Center for Integrative Medical Sciences, Yokohama, JapanDepartment of Biomedicine, University of Bergen, Bergen, NorwayLaboratory for Immune Cell Systems, RIKEN Center for Integrative Medical Sciences, Yokohama, JapanInnate lymphoid cells (ILCs) are mostly tissue resident lymphocytes that are preferentially enriched in barrier tissues such as the skin. Although they lack the expression of somatically rearranged antigen receptors present on T and B cells, ILCs partake in multiple immune pathways by regulating tissue inflammation and potentiating adaptive immunity. Emerging evidence indicates that ILCs play a critical role in the control of melanoma, a type of skin malignancy thought to trigger immunity mediated mainly by adaptive immune responses. Here, we compile our current understanding of ILCs with regard to their role as the first line of defence against melanoma development and progression. We also discuss areas that merit further investigation. We envisage that the possibility to harness therapeutic potential of ILCs might benefit patients suffering from skin malignancies such as melanoma.https://www.frontiersin.org/articles/10.3389/fimmu.2021.758522/fullinnate lymphoid cellsskinskin cancermelanomaimmunityimmunosurveillance |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marek Wagner Marek Wagner Shigeo Koyasu |
spellingShingle |
Marek Wagner Marek Wagner Shigeo Koyasu Innate Lymphoid Cells in Skin Homeostasis and Malignancy Frontiers in Immunology innate lymphoid cells skin skin cancer melanoma immunity immunosurveillance |
author_facet |
Marek Wagner Marek Wagner Shigeo Koyasu |
author_sort |
Marek Wagner |
title |
Innate Lymphoid Cells in Skin Homeostasis and Malignancy |
title_short |
Innate Lymphoid Cells in Skin Homeostasis and Malignancy |
title_full |
Innate Lymphoid Cells in Skin Homeostasis and Malignancy |
title_fullStr |
Innate Lymphoid Cells in Skin Homeostasis and Malignancy |
title_full_unstemmed |
Innate Lymphoid Cells in Skin Homeostasis and Malignancy |
title_sort |
innate lymphoid cells in skin homeostasis and malignancy |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2021-10-01 |
description |
Innate lymphoid cells (ILCs) are mostly tissue resident lymphocytes that are preferentially enriched in barrier tissues such as the skin. Although they lack the expression of somatically rearranged antigen receptors present on T and B cells, ILCs partake in multiple immune pathways by regulating tissue inflammation and potentiating adaptive immunity. Emerging evidence indicates that ILCs play a critical role in the control of melanoma, a type of skin malignancy thought to trigger immunity mediated mainly by adaptive immune responses. Here, we compile our current understanding of ILCs with regard to their role as the first line of defence against melanoma development and progression. We also discuss areas that merit further investigation. We envisage that the possibility to harness therapeutic potential of ILCs might benefit patients suffering from skin malignancies such as melanoma. |
topic |
innate lymphoid cells skin skin cancer melanoma immunity immunosurveillance |
url |
https://www.frontiersin.org/articles/10.3389/fimmu.2021.758522/full |
work_keys_str_mv |
AT marekwagner innatelymphoidcellsinskinhomeostasisandmalignancy AT marekwagner innatelymphoidcellsinskinhomeostasisandmalignancy AT shigeokoyasu innatelymphoidcellsinskinhomeostasisandmalignancy |
_version_ |
1716838679905828864 |